Commodore Capital’s Alpine Immune Sciences Inc ALPN Stock Holding History

Commodore Capital’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,375,000	Closed	-$54.5M	–	43
2024 Q1	$54.5M	Sell	1,375,000 -235,000	-15%	-$6.93M	3.64%	9
2023 Q4	$30.7M	Buy	1,610,000 +285,000	+22%	+$3.96M	2.68%	14
2023 Q3	$15.2M	Hold	1,325,000	–	–	1.77%	18
2023 Q2	$13.6M	Hold	1,325,000	–	–	1.53%	21
2023 Q1	$10.2M	Hold	1,325,000	–	–	1.56%	20
2022 Q4	$9.74M	Hold	1,325,000	–	–	1.47%	24
2022 Q3	$9.54M	Buy	+1,325,000	New	+$10.9M	1.53%	21

Commodore Capital's ALPN Position: Q2 2024 in Review

Commodore Capital sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 1,375,000 shares — an estimated $54.5M sold.

Commodore Capital first reported a position in ALPN in Q3 2022 and held it in 7 quarters. The position peaked at $54.5M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Commodore Capital reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Commodore Capital sold 1,375,000 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $54.5M.
Commodore Capital first reported a position in Alpine Immune Sciences Inc in Q3 2022 and held it in 7 quarters.
Commodore Capital's Alpine Immune Sciences Inc position peaked at $54.5M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Commodore Capital's 13F filing for Q2 2024, filed 14 Aug 2024.